abiraterone krka
krka, d.d., novo mesto - abiraterón acetátu - prostatické nádory - endokrinná terapia - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.
tatica 500 mg
egis pharmaceuticals plc, maďarsko - abirateron - 44 - cytostatica
tatica 250 mg
egis pharmaceuticals plc, maďarsko - abirateron - 44 - cytostatica
melatonin neurim
rad neurim pharmaceuticals eec sarl - melatonín - poruchy spánku a poruchy obsluhy - psycholeptika - melatonin neurim is indicated as monotherapy for the short-term treatment of primary insomnia characterised by poor quality of sleep in patients who are aged 55 or over.
daruph 111 mg
zentiva, k.s., Česká republika - dazatinib - 44 - cytostatica
daruph 79 mg
zentiva, k.s., Česká republika - dazatinib - 44 - cytostatica
daruph 63 mg
zentiva, k.s., Česká republika - dazatinib - 44 - cytostatica
daruph 55 mg
zentiva, k.s., Česká republika - dazatinib - 44 - cytostatica
daruph 40 mg
zentiva, k.s., Česká republika - dazatinib - 44 - cytostatica
daruph 16 mg
zentiva, k.s., Česká republika - dazatinib - 44 - cytostatica